101. The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes.
Wojtalla A, Herweck F, Granzow M, Klein S, Trebicka J, Huss S, Lerner R, Lutz B, Schildberg FA, Knolle PA, Sauerbruch T, Singer MV, Zimmer A, Siegmund SV
Am J Physiol Gastrointest Liver Physiol. 2012 Apr 15.
PMID: 22301114 [PubMed - in process]
102. In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration.
Beyer M, Schumak B, Weihrauch MR, Andres B, Giese T, Endl E, Knolle PA, Classen S, Limmer A, Schultze JL
PLoS One. 2012 .
PMID: 22276195 [PubMed - in process]
103. Toll-like receptor 2-mediated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vectors.
Hösel M, Broxtermann M, Janicki H, Esser K, Arzberger S, Hartmann P, Gillen S, Kleeff J, Stabenow D, Odenthal M, Knolle P, Hallek M, Protzer U, Büning H
Hepatology. 2012 Jan .
PMID: 21898480 [PubMed - in process]
104. Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic nanoparticle complexes.
Tresilwised N, Pithayanukul P, Holm PS, Schillinger U, Plank C, Mykhaylyk O
Biomaterials. 2012 Jan .
PMID: 21978891 [PubMed - in process]
105. Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10.
Schelter F, Grandl M, Seubert B, Schaten S, Hauser S, Gerg M, Boccaccio C, Comoglio P, Krüger A
Clin Exp Metastasis. 2011 Dec .
PMID: 21789719 [PubMed - in process]
106. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine.
Ari F, Napieralski R, Ulukaya E, Dere E, Colling C, Honert K, Krüger A, Kiechle M, Schmitt M
Cell Biochem Funct. 2011 Dec .
PMID: 21887697 [PubMed - in process]
107. Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery.
Klutz K, Willhauck MJ, Wunderlich N, Zach C, Anton M, Senekowitsch-Schmidtke R, Göke B, Spitzweg C
Hum Gene Ther. 2011 Nov .
PMID: 21488714 [PubMed - in process]
108. Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis.
Schwandt T, Schumak B, Gielen GH, Jüngerkes F, Schmidbauer P, Klocke K, Staratschek-Jox A, van Rooijen N, Kraal G, Ludwig-Portugall I, Franken L, Wehner S, Kalff JC, Weber O, Kirschning C, Coch C, Kalinke U, Wenzel J, Kurts C, Zawatzky R, Holzmann B, Layland L, Schultze JL, Burgdorf S, den Haan JM, Knolle PA, Limmer A
EMBO J. 2012 Jan 4.
PMID: 22036947 [PubMed - in process]
109. YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma.
Holzmüller R, Mantwill K, Haczek C, Rognoni E, Anton M, Kasajima A, Weichert W, Treue D, Lage H, Schuster T, Schlegel J, Gänsbacher B, Holm PS
Int J Cancer. 2011 Sep 1.
PMID: 21710499 [PubMed - in process]
110. Mechanisms balancing tolerance and immunity in the liver.
Böttcher JP, Knolle PA, Stabenow D
Dig Dis. 2011 .
PMID: 21894009 [PubMed - in process]